Featured 13F manager
Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site · 2021 Q3–2026 Q2
- $21.7B
- 77 Positions
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
Portfolio
top 5 29.9% · top 10 44.0%
- RVMD - Revolution Medicines 11.7%
- EA - Electronic Arts 7.5%
- BBIO - Bridgebio Pharma 3.7%
- PTGX - Protagonist Therapeutics 3.6%
- EXEL - Exelixis 3.4%
- LQDA - Liquidia 3.1%
- AMZN - Amazon 2.9%
- LNTH - Lantheus 2.9%
- NTRA - Natera 2.8%
- UNH - Unitedhealth Group 2.4%
- TMO - Thermo Fisher Scientific 2.4%
- ROIV - Roivant Sciences 2.3%
- Other 51.3%
AUM over time
Book
| RVMD - Revolution Medicines | 5.48% | Reduce −0.3% | 14,582,796 | $79.65 | $1.2B | −42,896 | +$478M |
| MSFT - Microsoft | 5.05% | Add +15.7% | 2,214,079 | $483.62 | $1.1B | +300,944 | +$80M |
| AMZN - Amazon | 4.90% | Add +28.4% | 4,499,894 | $230.82 | $1B | +994,194 | +$269M |
| AON - AON PLC · CL A | 4.44% | Add +17.0% | 2,665,238 | $352.88 | $941M | +387,221 | +$128M |
| NTRA - Natera | 4.23% | Reduce −8.0% | 3,914,366 | $229.09 | $897M | −339,086 | +$212M |
| BSX - Boston Scientific | 3.35% | Add +56.7% | 7,439,564 | $95.35 | $709M | +2,693,007 | +$246M |
| EXEL - Exelixis | 3.25% | Reduce −19.4% | 15,709,500 | $43.83 | $689M | −3,792,000 | −$117M |
| BBIO - Bridgebio Pharma | 3.25% | Add +9.8% | 8,998,463 | $76.49 | $688M | +806,463 | +$263M |
| PTGX - Protagonist Therapeutics | 2.53% | Reduce −0.8% | 6,144,006 | $87.34 | $537M | −52,000 | +$125M |
| WAB - Wabtec | 2.49% | Add +12.3% | 2,476,003 | $213.45 | $529M | +270,905 | +$86M |
| UNH - Unitedhealth Group | 2.49% | Reduce −15.2% | 1,598,906 | $330.11 | $528M | −287,594 | −$124M |
| Cyberark Software | 2.22% | New | 1,053,040 | $446.06 | $470M | +1,053,040 | +$470M |
| DIS - Disney Walt | 2.22% | Reduce −20.6% | 4,125,991 | $113.77 | $469M | −1,072,977 | −$126M |
| SNPS - Synopsys | 2.21% | New | 999,200 | $469.72 | $469M | +999,200 | +$469M |
| TMO - Thermo Fisher Scientific | 1.74% | Reduce −49.5% | 635,685 | $579.45 | $368M | −622,556 | −$242M |
| LNTH - Lantheus | 1.70% | Add +56.1% | 5,427,479 | $66.55 | $361M | +1,950,252 | +$183M |
| ARMK - Aramark | 1.63% | Add +4.0% | 9,357,046 | $36.86 | $345M | +360,844 | −$553K |
| CRM - Salesforce | 1.58% | Reduce −48.8% | 1,261,177 | $264.91 | $334M | −1,201,133 | −$249M |
| SCHW - Schwab Charles | 1.57% | Add +2.7% | 3,339,657 | $99.91 | $334M | +88,000 | +$23M |
| CRNX — | 1.52% | Add +20.2% | 6,933,098 | $46.55 | $323M | +1,163,000 | +$82M |
| AVGO - Broadcom | 1.46% | New | 892,400 | $346.10 | $309M | +892,400 | +$309M |
| LQDA - Liquidia | 1.41% | Add +1.1% | 8,656,038 | $34.49 | $299M | +90,400 | +$104M |
| NDAQ - Nasdaq | 1.37% | Reduce −17.5% | 2,989,213 | $97.13 | $290M | −633,830 | −$30M |
| BEAM - Beam Therapeutics | 1.32% | Hold | 10,063,111 | $27.72 | $279M | — | — |
| KKR — | 1.21% | New | 2,017,700 | $127.48 | $257M | +2,017,700 | +$257M |
| GOOG - Alphabet · CL C | 1.17% | Reduce −29.8% | 787,040 | $313.80 | $247M | −333,900 | −$26M |
| MCK - Mckesson | 1.16% | Reduce −8.6% | 298,900 | $820.29 | $245M | −28,200 | −$8M |
| V - VISA · CL A | 1.15% | Add +16.0% | 695,910 | $350.71 | $244M | +96,100 | +$39M |
| NYT - New York Times · CL A | 1.07% | Reduce −34.2% | 3,280,678 | $69.42 | $228M | −1,705,067 | −$58M |
| DAY - Dayforce | 0.95% | New | 2,925,000 | $69.16 | $202M | +2,925,000 | +$202M |
| GRAL - Grail | 0.95% | Add +73.7% | 2,342,684 | $85.59 | $201M | +993,684 | +$121M |
| BITW - Bitwise 10 Crypto Index ETF | 0.94% | New | 3,385,500 | $58.76 | $199M | +3,385,500 | +$199M |
| CBRE - CBRE Group · CL A | 0.75% | Reduce −39.1% | 983,771 | $160.79 | $158M | −632,267 | −$96M |
| AGIO - Agios Pharmaceuticals | 0.66% | Reduce −10.8% | 5,159,505 | $27.22 | $140M | −621,561 | −$92M |
| CNTA - Centessa Pharmaceuticals | 0.63% | Add +24.1% | 5,377,068 | $25.01 | $134M | +1,045,750 | +$29M |
| BBNX - Beta Bionics | 0.62% | Hold | 4,313,920 | $30.47 | $131M | — | — |
| CAH - Cardinal Health | 0.56% | Add +127.7% | 576,000 | $205.50 | $118M | +323,000 | +$79M |
| TNGX - Tango Therapeutics | 0.55% | Add +21.4% | 13,061,411 | $8.86 | $116M | +2,304,411 | +$25M |
| HIMS - Hims & Hers Health · CL A | 0.52% | Reduce −68.5% | 3,386,986 | $32.47 | $110M | −7,359,866 | −$500M |
| GBTC - Ishares Bitcoin Trust ETF | 0.50% | Reduce −69.4% | 2,137,100 | $49.65 | $106M | −4,855,600 | −$348M |
| MA - Mastercard · CL A | 0.47% | Reduce −19.2% | 172,671 | $570.88 | $99M | −41,100 | −$23M |
| CDTX - Cidara Therapeutics | 0.40% | Reduce −24.6% | 382,800 | $220.89 | $85M | −125,200 | +$36M |
| THC - Tenet Healthcare | 0.35% | Reduce −10.1% | 372,153 | $198.72 | $74M | −41,847 | −$10M |
| WELL - Welltower | 0.30% | New | 343,000 | $185.61 | $64M | +343,000 | +$64M |
| TRU - Transunion | 0.27% | Reduce −85.7% | 675,000 | $85.75 | $58M | −4,057,075 | −$339M |
| TYRA - Tyra Biosciences | 0.26% | Add +80.7% | 2,066,818 | $26.29 | $54M | +923,000 | +$38M |
| VNET - VNET Group | 0.25% | Add +14.5% | 6,285,386 | $8.46 | $53M | +796,266 | −$4M |
| ABVX - Abivax SA | 0.25% | Reduce −51.9% | 387,000 | $134.86 | $52M | −418,000 | −$16M |
| ENTA - Enanta Pharmaceuticals | 0.21% | Add +30.6% | 2,772,262 | $15.77 | $44M | +650,000 | +$18M |
| ASMB - Assembly Biosciences | 0.20% | Hold | 1,227,590 | $34.01 | $42M | — | — |
| BIDU - Baidu | 0.19% | Add +51.6% | 315,300 | $130.66 | $41M | +107,304 | +$14M |
| JOYY — | 0.18% | Reduce −7.5% | 578,200 | $64.76 | $37M | −46,800 | +$813K |
| ETHA - Ishares Ethereum Tr | 0.16% | Reduce −80.1% | 1,481,001 | $22.43 | $33M | −5,969,729 | −$202M |
| GPCR - Structure Therapeutics | 0.15% | New | 454,000 | $69.55 | $32M | +454,000 | +$32M |
| MLYS - Mineralys Therapeutics | 0.14% | Reduce −50.8% | 823,296 | $36.29 | $30M | −849,757 | −$34M |
| SUN - Sunococorp | 0.14% | New | 606,277 | $49.28 | $30M | +606,277 | +$30M |
| PCSC - Perceptive Cap Solutions · CL A | 0.14% | New | 2,250,000 | $13.03 | $29M | +2,250,000 | +$29M |
| TERN - Terns Pharmaceuticals | 0.12% | New | 642,000 | $40.40 | $26M | +642,000 | +$26M |
| EHC - Encompass Health | 0.12% | Reduce −58.9% | 234,500 | $106.14 | $25M | −336,500 | −$48M |
| AMKR - Amkor Technology | 0.09% | New | 464,000 | $39.48 | $18M | +464,000 | +$18M |
| VSTM - Verastem | 0.07% | New | 2,000,000 | $7.72 | $15M | +2,000,000 | +$15M |
| DOCS - Doximity · CL A | 0.06% | Reduce −16.8% | 311,000 | $44.28 | $14M | −63,000 | −$14M |
| GH - Guardant Health | 0.05% | Add +1262.5% | 109,000 | $102.14 | $11M | +101,000 | +$11M |
| MDLN - Medline · CL A | 0.05% | New | 260,000 | $42.00 | $11M | +260,000 | +$11M |
| EDU — | 0.05% | Reduce −65.3% | 196,000 | $55.03 | $11M | −369,150 | −$19M |
| NERV - Minerva Neurosciences | 0.04% | New | 2,365,000 | $4.02 | $10M | +2,365,000 | +$10M |
| WGS - Genedx · CL A | 0.04% | Add +1300.0% | 70,000 | $130.06 | $9M | +65,000 | +$9M |
| ETH — | 0.03% | New | 228,340 | $28.06 | $6M | +228,340 | +$6M |
| PRME - Prime Medicine | 0.02% | Reduce −73.9% | 1,240,843 | $3.47 | $4M | −3,509,157 | −$22M |
| OSCR - Oscar Health · CL A | 0.02% | Reduce −92.7% | 264,000 | $14.37 | $4M | −3,375,000 | −$65M |
| MDGL - Madrigal Pharmaceuticals | 0.01% | Hold | 3,319 | $582.34 | $2M | — | — |
| SMC - Summit Midstream | 0.01% | Hold | 58,214 | $26.68 | $2M | — | — |
| NVAX - Novavax | 0.01% | Reduce −75.0% | 195,000 | $6.72 | $1M | −585,000 | −$5M |
| SDGR - Schrodinger | 0.01% | Reduce −75.0% | 71,000 | $17.88 | $1M | −213,000 | −$4M |
| TEVA - Teva Pharmaceutical Inds | 0.01% | Reduce −99.2% | 40,000 | $31.21 | $1M | −4,957,000 | −$100M |
| CAPR - Capricor Therapeutics | 0.01% | Hold | 41,000 | $28.86 | $1M | — | — |
| ARWR - Arrowhead Pharmaceuticals | 0.00% | Hold | 15,800 | $66.39 | $1M | — | — |
| ALVO - Alvotech | 0.00% | Hold | 199,675 | $5.13 | $1M | — | — |
| BTSG - Brightspring Health Svcs | 0.00% | Hold | 22,000 | $37.45 | $824K | — | — |
| ROIV - Roivant Sciences | 0.00% | Hold | 37,000 | $21.70 | $803K | — | — |
| ARQT - Arcutis Biotherapeutics | 0.00% | Hold | 26,000 | $29.04 | $755K | — | — |
| AXSM - Axsome Therapeutics | 0.00% | Hold | 4,000 | $182.64 | $731K | — | — |
| COGT - Cogent Biosciences | 0.00% | Hold | 17,000 | $35.52 | $604K | — | — |
| ALKS - Alkermes | 0.00% | Hold | 20,800 | $27.98 | $582K | — | — |
| INSM - Insmed | 0.00% | Hold | 3,000 | $174.04 | $522K | — | — |
| KRYS - Krystal Biotech | 0.00% | Hold | 2,000 | $246.54 | $493K | — | — |
| PGNY - Progyny | 0.00% | Hold | 18,000 | $25.68 | $462K | — | — |
| TVTX - Travere Therapeutics | 0.00% | Hold | 12,000 | $38.21 | $459K | — | — |
| HQY - Healthequity | 0.00% | Hold | 5,000 | $91.61 | $458K | — | — |
| IONS - Ionis Pharmaceuticals | 0.00% | Hold | 4,800 | $79.11 | $380K | — | — |
| LIVN - Livanova | 0.00% | Hold | 6,000 | $61.53 | $369K | — | — |
| GMED - Globus Med · CL A | 0.00% | Hold | 4,000 | $87.31 | $349K | — | — |
| COR - Cencora | 0.00% | Hold | 1,000 | $337.75 | $338K | — | — |
| QURE - Uniqure | 0.00% | Reduce −97.5% | 14,000 | $23.93 | $335K | −551,000 | −$33M |
| ONC - Beone Medicines | 0.00% | Hold | 1,100 | $303.81 | $334K | — | — |
| CGON - Cg Oncology | 0.00% | Hold | 8,000 | $41.52 | $332K | — | — |
| SRRK - Scholar Rock | 0.00% | Hold | 7,000 | $44.05 | $308K | — | — |
| IMVT - Immunovant | 0.00% | Hold | 12,000 | $25.42 | $305K | — | — |
| NUVL - Nuvalent | 0.00% | Hold | 3,000 | $100.59 | $302K | — | — |
| ASND - Ascendis Pharma A/S | 0.00% | Hold | 1,400 | $213.24 | $299K | — | — |
| VCYT - Veracyte | 0.00% | Hold | 7,000 | $42.10 | $295K | — | — |
| GKOS - Glaukos | 0.00% | Hold | 2,600 | $112.91 | $294K | — | — |
| SBRA - Sabra Health Care Reit | 0.00% | Hold | 14,000 | $18.94 | $265K | — | — |
| MMSI - Merit Med Sys | 0.00% | Hold | 3,000 | $88.14 | $264K | — | — |
| GRFS - Grifols S A | 0.00% | Hold | 28,000 | $9.35 | $262K | — | — |
| ACLXGBX - Arcellx | 0.00% | Hold | 4,000 | $65.20 | $261K | — | — |
| URGN - Urogen Pharma | 0.00% | Hold | 11,000 | $23.42 | $258K | — | — |
| PACB — | 0.00% | Hold | 135,000 | $1.87 | $252K | — | — |
| GEHC - GE HealthCare | 0.00% | Hold | 3,000 | $82.02 | $246K | — | — |
| TWST - Twist Bioscience | 0.00% | Hold | 7,650 | $31.72 | $243K | — | — |
| MIRM - Mirum Pharmaceuticals | 0.00% | Hold | 3,000 | $78.99 | $237K | — | — |
| SLNOEUR - Soleno Therapeutics | 0.00% | Reduce −96.7% | 5,000 | $46.30 | $232K | −148,000 | −$10M |
| AM6 - Amicus Therapeutics | 0.00% | Hold | 16,000 | $14.24 | $228K | — | — |
| ANNA - Aleanna · CL A | 0.00% | Hold | 78,400 | $2.85 | $223K | — | — |
| ICLR - ICON | 0.00% | Hold | 1,200 | $182.22 | $219K | — | — |
| SNDX - Syndax Pharmaceuticals | 0.00% | Hold | 10,000 | $21.01 | $210K | — | — |
| HR - Healthcare Rlty Tr · CL A | 0.00% | Hold | 12,000 | $16.95 | $203K | — | — |
| DYN - Dyne Therapeutics | 0.00% | Hold | 10,000 | $19.56 | $196K | — | — |
| BCRX - Biocryst Pharmaceuticals | 0.00% | Hold | 24,000 | $7.80 | $187K | — | — |
| TVRD - Tvardi Therapeutics | 0.00% | Hold | 43,225 | $4.30 | $186K | — | — |
| ARDX - Ardelyx | 0.00% | Hold | 23,000 | $5.83 | $134K | — | — |
| ALT - Altimmune | 0.00% | Hold | 27,600 | $3.61 | $100K | — | — |
| IOVA - Iovance Biotherapeutics | 0.00% | Hold | 26,000 | $2.73 | $71K | — | — |
| GERN - Geron | 0.00% | Hold | 43,000 | $1.32 | $57K | — | — |
| EVH - Evolent Health · CL A | 0.00% | Hold | 14,000 | $4.00 | $56K | — | — |
| CCCC - C4 Therapeutics | 0.00% | Hold | 28,000 | $1.91 | $53K | — | — |
| IRWD - Ironwood Pharmaceuticals · CL A | 0.00% | Hold | 13,000 | $3.37 | $44K | — | — |
| CGC - Canopy Growth | 0.00% | Hold | 30,000 | $1.14 | $34K | — | — |
Showing top 50 of 128 by value
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2025 Q3
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| ADSK - Autodesk | 2.16% | Exit | 0 | $317.67 | $528M | −1,662,852 | −$528M |
| INTU - Intuit | 1.36% | Exit | 0 | $682.91 | $333M | −488,088 | −$333M |
| K - Kellanova | 1.32% | Exit | 0 | $82.02 | $323M | −3,943,853 | −$323M |
| ADI - Analog Devices | 1.31% | Exit | 0 | $245.70 | $319M | −1,299,500 | −$319M |
| NSC - Norfolk Southn | 0.76% | Exit | 0 | $300.41 | $185M | −615,000 | −$185M |
| IQV - IQVIA | 0.73% | Exit | 0 | $189.94 | $178M | −938,551 | −$178M |
| WWD - Woodward | 0.64% | Exit | 0 | $252.71 | $157M | −621,973 | −$157M |
| MARA | 0.27% | Exit | 0 | $18.26 | $67M | −3,660,000 | −$67M |
| Grayscale Coindesk Crypto | 0.19% | Exit | 0 | $55.90 | $48M | −851,193 | −$48M |
| Mr Cooper Group | 0.19% | Exit | 0 | $210.79 | $47M | −222,000 | −$47M |
| NKTR - Nektar Therapeutics | 0.18% | Exit | 0 | $56.90 | $45M | −791,000 | −$45M |
| FLUT - Flutter Entmt | 0.14% | Exit | 0 | $254.00 | $35M | −137,369 | −$35M |
| WAY - Waystar | 0.12% | Exit | 0 | $37.92 | $28M | −750,000 | −$28M |
| SGRY - Surgery Partners | 0.08% | Exit | 0 | $21.64 | $19M | −871,830 | −$19M |
| INTC - Intellia Therapeutics | 0.04% | Exit | 0 | $17.27 | $10M | −607,200 | −$10M |
| TECX - Tectonic Therapeutic | 0.04% | Exit | 0 | $15.69 | $10M | −640,000 | −$10M |
| Savara | 0.04% | Exit | 0 | $3.57 | $9M | −2,500,000 | −$9M |
| Ishares Tr | 0.02% | Exit | 0 | $271.12 | $5M | −18,907 | −$5M |
| Allete | 0.02% | Exit | 0 | $66.40 | $5M | −75,000 | −$5M |
| Merus | — | Exit | 0 | $94.00 | $282K | −3,000 | −$282K |
| RARE — | — | Exit | 0 | $30.14 | $211K | −7,000 | −$211K |
| Beyond Meat | — | Exit | 0 | $1.89 | $36K | −19,000 | −$36K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
FARALLON CAPITAL MANAGEMENT, L.L.C.
87 processed 13Fs on this site · 2021 Q3–2026 Q2